QIAGEN N.V.: BlackRock Reports 12.90% Voting Rights
QIAGEN N.V. disclosed an AFM notice stating that BlackRock, Inc., through various entities, held an 11.51% capital interest and a 12.90% voting rights stake in QIAGEN as of September 29, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.